Sun Pharma recalls Testosterone Cypionate injection from US market

31 Mar 2017 Evaluate

Sun Pharmaceutical Industries is recalling 83,188 single dose vials of Testosterone Cypionate injection USP, 200 mg/mL, 1 mL vial on account of ‘presence of particulate matter’. The injection is indicated for replacement therapy in males in conditions associated with symptoms of deficiency or absence of endogenous testosterone.

As per the the United States Food and Drug Administration (USFDA) the nationwide ongoing voluntary recall by the firm is a class II recall.

Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

Sun Pharma Inds. Share Price

1720.40 0.65 (0.04%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×